Clinical Trial Update: Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates [Phase 1]

View source ↗

Summary

Phase 1 trial evaluated pharmacokinetic interactions between MDV3100 (enzalutamide) and a substrate cocktail. The study, conducted in castration-resistant prost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Cocktail of substrates for drug-drug interaction study
• MDV3100 (enzalutamide)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Pharmacokinetics of MDV3100, Castration Resistant Prostate Cancer (CRPC) | Phase 1 | Status: COMPLETED